Fitterfly HealthTech Pvt Ltd Logo
< Back to Listing
Conference abstracts Conference abstracts
82nd Scientific Session, American Diabetes Association
Jun 2022 | Poster | By Dr Ritika Verma, Saimala Guntur, Dr.Tejal Lathia , Nikhil Chitnis, Sneha Kothari, Piya Ballani, Akshata Agnihotri, Dr. Snehal Tanna, Dr Arbinder Kumar Singal

Significant Weight Reduction and Improvement in Glycemic Control Among People With T2D After Participation in Diabefly® Digital Therapeutics Program.

This study explored effectiveness of the Diabefly® program for improving glycemic control among 172 participants with T2D. Significant reduction in HbA1c, weight, BMI, FBS and PPBS by 1.69%, 2.59kg, 0.92 kg/m2, 51.44mg/dL, and 90.90 mg/dLwas observed respectively. 93.02% participants reduced their HbA1c levels and among them 56.25% showed a reduction of more than 1% in HbA1c. Similarly, 70.34% participants reduced their weight. Effective glycemic control and significant weight reduction was achieved at the end of the program.

Read full paper